http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9209624-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0205 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02 |
| filingDate | 1991-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72d2fba8132f8fdaa4a6b1a3a0497363 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f000dec13856a43b42397703c0b45d2 |
| publicationDate | 1992-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9209624-A1 |
| titleOfInvention | Novel renin inhibiting peptides |
| abstract | The invention concerns certain orally active renin-inhibitory peptides having one of the structures: (I) or a pharmaceutically acceptable salt thereof, or (II) or a pharmaceutically acceptable salt thereof. They are useful for treating renin-associated hypertension, congestive heart failure, hyperaldosteronism, and glaucoma. They are also useful for treating diseases caused by retroviruses including HTLV-I, -II and -III. Process for preparing the peptides, compositions containing them, and methods of using them are included. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension, congestive heart failure, or hyperaldosteronism. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5969132-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9521186-A1 |
| priorityDate | 1990-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.